Global Insulin Pen Needles Market Growth 2023-2029

Global Insulin Pen Needles Market Growth 2023-2029

Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are used by both health professionals and patients for injection of a variety of medications. They are commonly used by people with diabetes who often require multiple daily insulin injections.
LPI (LP Information)' newest research report, the “Insulin Pen Needles Industry Forecast” looks at past sales and reviews total world Insulin Pen Needles sales in 2022, providing a comprehensive analysis by region and market sector of projected Insulin Pen Needles sales for 2023 through 2029. With Insulin Pen Needles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulin Pen Needles industry.
This Insight Report provides a comprehensive analysis of the global Insulin Pen Needles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insulin Pen Needles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Insulin Pen Needles market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulin Pen Needles and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulin Pen Needles.
The global Insulin Pen Needles market size is projected to grow from US$ 1801 million in 2022 to US$ 2530.6 million in 2029; it is expected to grow at a CAGR of 2530.6 from 2023 to 2029.
Global Insulin Pen Needles key players include BD, Novo Nordisk, Artsana, B. Braun, Terumo, etc. Global top five manufacturers hold a share about 70%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 40 percent. In terms of product, Standard Insulin Pen Needles is the largest segment, with a share about 95%. And in terms of application, the largest application is Home Use, followed by Medical Institutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Pen Needles market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Standard Insulin Pen Needles
Safety Insulin Pen Needles
Segmentation by application
Home Use
Medical Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Dongbao
Key Questions Addressed in this Report
What is the 10-year outlook for the global Insulin Pen Needles market?
What factors are driving Insulin Pen Needles market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Insulin Pen Needles market opportunities vary by end market size?
How does Insulin Pen Needles break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.